Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESCUE-Combo: Combination Drug Therapy for OSA
NCT04639193Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Dec 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetazolamide, eszopiclone and venlafaxine in obstructive sleep apnea (OSA) (2 arms), sponsored by University of California, San Diego. Primary endpoint: Apnea Hypopnea Index. Started Dec 2020; status: completed.
02
Drugs
acetazolamideeszopiclonevenlafaxine
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT04639193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04639193.